Nanotechnology approaches for restoring sight in patients with retinal degenerative diseases offer potential advantages compared with a retinal prosthesis, says Marco A. Zarbin, MD, PhD.
As the Archway study is getting under way, investigators are being trained in the procedures for implanting and refilling a port delivery system, notes Dante J. Pieramici, MD.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
